反応式
[NH2:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([C:10]2[CH:15]=[CH:14][C:13]([O:16][CH2:17][CH2:18][O:19][CH3:20])=[CH:12][CH:11]=2)[C:5]([C:21]#[N:22])=[C:4]([SH:23])[N:3]=1.Br[CH:25]([C:27]1[CH:28]=[C:29]([C:33]([O:35][CH3:36])=[O:34])[CH:30]=[CH:31][CH:32]=1)[CH3:26].C(=O)(O)[O-].[Na+].O>CN(C=O)C>[NH2:1][C:2]1[N:3]=[C:4]([S:23][CH:25]([C:27]2[CH:28]=[C:29]([C:33]([O:35][CH3:36])=[O:34])[CH:30]=[CH:31][CH:32]=2)[CH3:26])[C:5]([C:21]#[N:22])=[C:6]([C:10]2[CH:11]=[CH:12][C:13]([O:16][CH2:17][CH2:18][O:19][CH3:20])=[CH:14][CH:15]=2)[C:7]=1[C:8]#[N:9]参加物
6
実験手順
300 mg (0.919 mmol) of 2-amino-4-[4-(2-methoxyethoxy)phenyl]-6-sulfanylpyridine-3,5-dicarbonitrile (Example 15A), 245 mg (1.01 mmol) of methyl 3-(1-bromoethyl)benzenecarboxylate (Example 61A) and 231 mg (2.76 mmol) of sodium bicarbonate were dissolved in 3 ml of DMF and the mixture was stirred at RT overnight. Water was added to the reaction mixture until a clear solution had formed. The solution was purified by preparative HPLC (Chromasil, water/acetonitrile+0.1% trifluoroacetic acid).
後処理
- customhad formed
- customThe solution was purified by preparative HPLC (Chromasil, water/acetonitrile+0.1% trifluoroacetic acid)
出典と根拠
- ORDレコード
- ord-db85723dec71408d9e68fd31250524fd
- 出典データセット
- uspto-grants-2015_11
- 特許番号
- US09187428B2
関連ノート
読み込み中…